The real drug development delay? Bad communication.
Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
Biotech companies are spending billions to perfect chemical formulas, only to be tripped up by the one variable they forgot ...
Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal ...
Australian pharmaceutical and biotechnology start-ups are already looking to take their investments to jurisdictions ...
In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...
The companies will work together to launch and scale new biotechnology companies using AI to accelerate drug development.
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
The biotechnology company will use the federal pilot program for its planned $2 billion Saratoga Springs manufacturing campus ...
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...
11h
A drug already in human trials could reverse tooth loss by 2030, a condition that affects millions
A Japanese biotech company is testing a drug designed to do what modern dentistry has never managed: regrow real, natural ...
Speaking to media on Tuesday, BIO CEO John Crowley complimented China’s rise as a biotech powerhouse but said U.S. policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results